MojoSort Human anti-PE Nanobeads 1 mL
Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
Points clés
Human PE labeled PBMCs are either selected or depleted in a two-step separation process. The cells are first incubated with a BioLegend anti-human PE-conjugated antibody, followed by incubating with directly conjugated anti-PE Nanobeads. The PE+, magnetically labeled fraction is retained by the use of a magnetic separator. After collection or depletion of the PE+ cells, downstream applications include functional assays, gene expression, phenotypic characterization, etc;
Garantie
Garantie 0 Mois
Description
Human PE labeled PBMCs are either selected or depleted in a two-step separation process. The cells are first incubated with a BioLegend anti-human PE-conjugated antibody, followed by incubating with directly conjugated anti-PE Nanobeads. The PE+, magnetically labeled fraction is retained by the use of a magnetic separator. After collection or depletion of the PE+ cells, downstream applications include functional assays, gene expression, phenotypic characterization, etc;
Caractéristiques
- Fournisseur
- BioLegend Europe BV
- Marque
- BIOLEGEND
- Référence fabricant
- 480092
- Référence distributeur
- 480092
- Vendu par
- 1 ml
- Quantité
- N/A
- Lieu de fabrication
- USA
- Lieu de stockage
- Pays-Bas ou USA
- Soumis à carboglace
- non
- Classement dans le catalogue fournisseur
- Cell Separation
- Certification
- RUO
- Type d’application
- cell separation pos and neg
- Type de produit
- Cell Separation
- Température de conservation (°C)
- entre 2 et 8 °C
- Température de transport
- ambiante
- Méthode d'isolement
- bille magnétique
- Organisme cible
- Human
- Matière dangereuse
- non
- Code douanier
- 38220000
- Nomenclature Nacres
- NA.82
- Nomenclature CEA
- SGP01
- Nomenclature IRSN
- 273
- Nomenclature INSERM
- NA.NA82
- Nomenclature CNRS
- NA82
- Nomenclature CHU
- 18.551
- Nomenclature DGOS
- LD11AOOO
- Reprise en cas d’erreur client
- non